About Steve Liapis
Form D filings for Garuda Therapeutics in 2024 list Steve Liapis as director.
Steve Liapis first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Steve Liapis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steve Liapis works with at each company, as listed on that company's latest Form D.
Garuda Therapeutics, Inc. · Form D, Oct 31, 2024
GM
Geoff Meyerson
Director
RK
Raymond Kelleher
Director
EA
Eric Aguiar
Director
RS
Rahul Singhvi
Director
DK
David Kirske
Executive officer
CG
Carl Gordon
Director
AC
Adam Craig
President and CEO, director